(E)-N-(4-Cinnamoylphenyl)thieno[2,3-b]quinoline-2-carboxamide

ID: ALA4546479

PubChem CID: 155552324

Max Phase: Preclinical

Molecular Formula: C27H18N2O2S

Molecular Weight: 434.52

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(/C=C/c1ccccc1)c1ccc(NC(=O)c2cc3cc4ccccc4nc3s2)cc1

Standard InChI:  InChI=1S/C27H18N2O2S/c30-24(15-10-18-6-2-1-3-7-18)19-11-13-22(14-12-19)28-26(31)25-17-21-16-20-8-4-5-9-23(20)29-27(21)32-25/h1-17H,(H,28,31)/b15-10+

Standard InChI Key:  IGQGYVKRVJTVBZ-XNTDXEJSSA-N

Molfile:  

 
     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
    2.8175  -27.8422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8163  -28.6618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5244  -29.0707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5226  -27.4334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2312  -27.8386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2320  -28.6577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9405  -29.0647    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9349  -27.4284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6440  -27.8318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6517  -28.6508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4330  -28.8967    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.9083  -28.2296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4207  -27.5715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7255  -28.2219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1407  -28.9258    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.1275  -27.5104    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.9578  -28.9181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3683  -29.6228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1847  -29.6155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5875  -28.9035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1679  -28.1973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3528  -28.2081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4046  -28.8948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8207  -29.5981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8056  -28.1827    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.6379  -29.5893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0540  -30.2926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6519  -31.0019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0673  -31.7047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8853  -31.6964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2861  -30.9794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8684  -30.2796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7 10  2  0
  9  8  2  0
  8  5  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13  9  1  0
 12 14  1  0
 14 15  1  0
 14 16  2  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 20 23  1  0
 23 24  1  0
 23 25  2  0
 24 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4546479

    ---

Associated Targets(Human)

MIA PaCa-2 (5949 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PANC-1 (6144 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-375 (9258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF-10A (2462 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 434.52Molecular Weight (Monoisotopic): 434.1089AlogP: 6.60#Rotatable Bonds: 5
Polar Surface Area: 59.06Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.63CX Basic pKa: 3.79CX LogP: 6.52CX LogD: 6.52
Aromatic Rings: 5Heavy Atoms: 32QED Weighted: 0.25Np Likeness Score: -1.18

References

1. Abdelbaset MS, Abdel-Aziz M, Ramadan M, Abdelrahman MH, Abbas Bukhari SN, Ali TFS, Abuo-Rahma GEA..  (2019)  Discovery of novel thienoquinoline-2-carboxamide chalcone derivatives as antiproliferative EGFR tyrosine kinase inhibitors.,  27  (6): [PMID:30744932] [10.1016/j.bmc.2019.02.012]

Source